Company Updates

RewardBet.com provides what’s been called the most innovative product for wagering and gaming in decades. Shareholders include significant industry representatives and specialists. In an industry that is very competitive but also extremely profitable, RewardBet was granted/accepted four patents in South Africa, Singapore, New Zealand and Australia this year. There are around 50 countries pending. Highlights […]

Atomo Diagnostics secures commitments for over US$8 million to support continued global rollout Atomo has executed a Term Sheet with a leading Global Impact Fund and received preliminary board approval from the fund for an investment totalling US$8million. The investment, a combination of a loan and equity, will be used to scale up of Atomo’s manufacturing […]

15th December 2015, ASX Announcement OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce the appointment of Mr. Charles Rowland as President, OncoSil Medical USA. Mr. Rowland was previously President of Sirtex Medical US from 2002 to 2006, and is a highly experienced healthcare executive with a successful record of commercialising […]

13th December 2015, The New York Times By Nick Wingfield Magic Leap, a secretive company making wearable technology for mixing digital imagery with the real world, is seeking to raise $827 million. Jaunt, maker of a 3-D camera for filming virtual reality video, has nabbed a total of $100 million, including $65 million in September. […]

14th December 2015, ASX Announcement BPS Technology Limited (“BPS”) (ASX:BPS) is pleased to announce it has finalised the issue and placement of Convertible Notes at $1.175 per share conversion ratio and raising a total of $5 million on terms favourable to the Company. Key highlights:  Strongly supported institutional placement Three new Listed Investment Companies join […]

14th December 2015, ASX Announcement The Board of YPB Group Limited (ASX:YPB) advises that the Company is in continuing discussions with potential cornerstone investors to support the continuing growth of the business. The purpose of the proposed capital raising is to fund the previously announced pending acquisition of Motif Micro Inc. and provide additional working […]

14th December 2015, ASX Announcement OncoSil Medical Lmited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce that it has filed an Investigational Device Exemption (IDE) with the US Food and Drug Administration (FDA) for its lead product candidate, the OncoSilTM localised radiation treatment for cancer. This is a significant milestone in the development […]

11th December 2015, ASX Announcement Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (the Company) is pleased to advise that recording of an interview of the Company’s CEO Domenic Carosa, by Tom Piotrowski of CommSec is available for viewing on the Company’s website. To watch, please click here.  To read the full announcement, please click […]

10th December 2015, ASX Announcement SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today announces that it has amended its agreement with Amherst Pharmaceuticals in relation to ZolpiMist for insomnia and SUD-002 for nausea and vomiting. Under the terms of the new agreement, SUDA has expanded it territorial rights to ZolpiMist to include […]